ABLYNX ANNOUNCES WARRANT EXERCISE
Sep 14, 2017 05:02 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 14 September 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008,...
Diet Doc’s ‘JumpStart Diet’ Leads Patients to Rapid Weight Loss and Reduced Blood Pressure Levels
Sep 14, 2017 05:00 am UTC| Business
Jackson, MS, Sept. 14, 2017 -- According to the National Institute of Health, high blood pressure or hypertension is a major health problem in the U.S., that affects more than 50 million people. Although high blood...
TORA Named Best OMS Provider at HFM European Hedge Fund Technology Awards
Sep 14, 2017 04:05 am UTC| Business
LONDON, Sept. 14, 2017 -- TORA today announced that it has been named "Best OMS Provider" at the HFM European Hedge Fund Technology Awards. The awards, presented on September 12 at a ceremony in London, recognize...
Sep 14, 2017 04:01 am UTC| Business
AMSTERDAM, Netherlands, Sept. 13, 2017 -- IBC2017 – Quantenna Communications, Inc. (Nasdaq:QTNA), a leading provider of high performance Wi-Fi solutions, announced that Technicolor, a worldwide technology leader in...
Sep 14, 2017 04:01 am UTC| Business
NEW YORK, Sept. 14, 2017 -- Thank You For Joining Us "In The Boardroom" On SecuritySolutionsWatch.Com Kurt Takahashi, President, AMAG Technology - A G4S CompanyMarc Blackmer, Cisco, Product Marketing Manager,...
Standard Chartered Completes Strategic Investment and Joint Innovation Agreement with Paxata
Sep 14, 2017 04:00 am UTC| Business
SINGAPORE, Sept. 14, 2017 -- Standard Chartered has made a strategic investment and entered into a joint innovation agreement with Paxata, a leading enterprise information management company based in Redwood City,...
Summit Therapeutics Announces Pricing of Public Offering of 1,459,000 American Depositary Shares
Sep 14, 2017 03:03 am UTC| Business
OXFORD, United Kingdom, Sept. 13, 2017 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection,...